XML 33 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity (Tables)
12 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
Schedule of analysis of option activity

As of March 31, 2023

 

Range of Exercise Prices

 

Options Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$148

 

 

0.3

 

 

 

2.25

 

 

$

148

 

 

$

 

$280 - $488

 

 

10.0

 

 

 

0.50

 

 

$

290

 

 

 

 

 

 

10.2

 

 

 

0.54

 

 

$

287

 

 

$

 

 

As of March 31, 2022

 

Range of Exercise Prices

 

Options Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$148

 

 

0.3

 

 

 

3.25

 

 

$

148

 

 

$

 

$280 - $488

 

 

10.6

 

 

 

1.50

 

 

 

290

 

 

 

 

 

 

10.9

 

 

 

1.54

 

 

$

287

 

 

$

 

A
Schedule of stock appreciation rights outstanding

As of March 31, 2023

 

Range of Prices

 

SARs Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$7.80 - $14.80

 

 

430

 

 

 

8.37

 

 

$

11.15

 

 

$

3

 

$23.20 - $29.40

 

 

105

 

 

 

6.25

 

 

 

27.62

 

 

 

 

$34.20 - $42.00

 

 

100

 

 

 

8.78

 

 

 

40.18

 

 

 

 

$44.60 - $51.20

 

 

21

 

 

 

8.57

 

 

 

45.46

 

 

 

 

 

 

 

657

 

 

 

8.10

 

 

$

19.33

 

 

$

3

 

 

As of March 31, 2022

 

Range of Prices

 

SARs Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$10.80 - $14.80

 

 

278

 

 

 

8.74

 

 

$

12.40

 

 

$

1,208

 

$23.20 - $29.40

 

 

114

 

 

 

7.90

 

 

 

27.40

 

 

 

 

$34.20 - $42.00

 

 

123

 

 

 

8.91

 

 

 

39.40

 

 

 

 

$44.60 - $51.20

 

 

30

 

 

 

9.60

 

 

 

46.40

 

 

 

 

 

 

 

545

 

 

 

8.65

 

 

$

23.52

 

 

$

1,208

 

SARs Exercisable
(In thousands)

 

 

Weighted Average
Remaining Life in Years

 

 

Weighted Average
Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

 

424

 

 

 

7.6

 

 

$

20.46

 

 

$

 

Schedule of weighted average assumptions used to estimate fair value of SARs

The following weighted average assumptions were used to estimate the fair value of SARs granted, as follows:

 

 

For the Year Ended March 31,

 

 

 

2023

 

 

2022

 

Expected dividend yield

 

 

 

 

 

 

Expected equity volatility

 

 

112

%

 

95% - 114%

 

Expected term (years)

 

 

6.50

 

 

6.0 - 6.5

 

Risk-free interest rate

 

 

4.49

%

 

0.96% - 1.63%

 

Exercise price

 

$

9.82

 

 

$25.80-$51.20

 

Market price per share

 

$

9.82

 

 

$25.80-$51.20

 

Schedule of SARs outstanding

 

 

Year Ended
March 31, 2023

 

March 31, 2022

 

 

545

 

Issued

 

 

155

 

Forfeited

 

 

(43

)

March 31, 2023

 

 

657